PDEX· Health Care› Medical Instruments & Supplies

Pro-Dex, Inc.

Stage 2 · Advancing · week 36

As of Oct 22, 2026, Pro-Dex is in Stage 2, the uptrend phase, now in week 36 (since Feb 10, 2026). It closed at $62.38, 15.0% below its 52-week high and above its 200-day average, which is rising.

Pro-Dex, Inc. designs, develops, manufactures, and repairs powered surgical instruments for medical device original equipment manufacturers worldwide. More about the company

$62.38

+3.01% today

$202M · Micro cap

Market Neutral — Building

Pro read

Pro

Our read

In Stage 2, but it has already run

Setup score

—

Momentum

Steady

Edge

—

Setup-score rank among Stage 2 peers: #1 of 18 in Medical Instruments & Supplies · #1 of 272 in Health Care

Is PDEX early, or has it already run? Pro answers that for every US stock we cover, after every close.

Get Pro · $19 a month

Renews monthly until you cancel. Cancel any time in Plan & billing.

Loading price chart…

Stage Cycle Timeline2023-08-16 → 2026-10-22

S2 39w

S2 36w

2023-08-162026-10-22

S1S2S3S4Setup score (0–10, dashed line at 5)

S2 1w → S3 5w → S4 6w → S1 8w → S2 11w → S3 8w → S2 39w → S3 7w → S2 9w → S3 6w → S4 3w → S1 4w → S2 1w → S1 2w → S4 12w → S1 9w → S2 36w current

Total tracked: 166 weeks across 17 stage runs.

PDEX among Medical Instruments & Supplies2nd of 51 by relative strength

All 51 →

Stocks in Medical Instruments & Supplies ranked by relative strength, with stage and one-month change
#	Stock	Stage	RS	1M
1	PLSEPulse Biosciences, Inc	Stage 2 · wk 34	98	+1.3%
2	PDEXPro-Dex, Inc.	Stage 2 · wk 36	97	−13.3%
3	HBIOHarvard Bioscience, Inc.	Stage 2 · wk 11	95	+3.6%
4	ATRCAtriCure, Inc.	Stage 2 · wk 10	89	−1.1%
5	WSTWest Pharmaceutical Services, Inc.	Stage 2 · wk 24	82	+4.8%
6	BDXBecton, Dickinson and Company	Stage 2 · wk 11	81	+9.8%
7	ICUIICU Medical, Inc.	Stage 3 · wk 1	81	+3.1%
8	OSUROraSure Technologies, Inc.	Stage 3 · wk 8	75	−4.8%

vs 52W High

-15.0%

$26.36 lo$73.41 hi

15.0% below 52W high, deeper pullback

How far this stock is from its 52-week high. A pullback of 3–20% while Stage 2 structure holds is typically a better entry than chasing near the high.

Stage Maturity

Week 36

1w13w26w

Week 36, mature

How long this stock has been in Stage 2. The sweet spot is mid-run: long enough to prove the structure holds, not so long that it's extended. Very fresh moves (weeks 1–4) often need more time to confirm.

vs 200 DMA

11.5%

200 DMA: $55.96 · rising

Long-term trend anchor. When the stock and the S&P 500 are both above their 200-day averages, the backdrop supports continuation.

Rel Volume

0.37x

vs 50-day avg

Low vol (0.5–1x) on pullbacks = resting, not being sold. High vol on breakouts = commitment. Volume spike on down days is a warning sign.

Trend Health

↓

Short-term trend rolling over

Two reads of momentum. The arrow shows the direction of the short-term trend: rising (↑ or ↗), flat (→) or rolling over (↓). The ⇈ mark appears when our trend model reads the move as gaining speed on top of the longer trend. Strongest when both agree.

-13.3%

+13.6%

+22.4%

YTD

+65.4%

+139.2%

Scan Membership

Breakout Watch

Latest: 2025-04-03

10 appearances in last 60 days. First seen: 2018-10-16.

A stock that keeps qualifying week after week does so because its Stage 2 structure keeps holding. Staying power in the scan says more about the trend than any single appearance.

Recent Stage Timeline

2026-10-22S2

Wk 36 · Vol 0.37x

2026-10-21S2

Wk 36 · Vol 0.28x

2026-10-20S2

Wk 35 · Vol 0.36x

2026-10-19S2

Wk 35 · Vol 0.50x

2026-10-16S2

Wk 35 · Vol 0.32x

2026-10-15S2

Wk 35 · Vol 0.46x

2026-10-14S2

Wk 35 · Vol 0.88x

2026-10-13S2

Wk 34 · Vol 0.41x

2026-10-12S2

Wk 34 · Vol 0.94x

2026-10-09S2

Wk 34 · Vol 0.44x

2026-10-08S2

Wk 34 · Vol 0.65x

2026-10-07S2

Wk 34 · Vol 0.60x

Moving averages & range

50 DMA

$65.45

200 DMA

$55.96

52W High

$73.41

52W Low

$26.36

5D Low

$57.70

Resistance levels (recent highs)

20d High

$71.77

60d High

$73.41

120d High

$73.41

250d High

$73.41

Next resistance

+15.1%

to 20d High

P/E (TTM)

15.1

Forward 18.6

Earnings Growth (YoY)

+143.4%

Revenue +16.6%

ROE

+32.4%

Profit margin +17.6%

Dividend Yield

0.00%

P/B 4.2

Pro-Dex: quick answers

What stage is Pro-Dex in?

As of Oct 22, 2026, Pro-Dex (PDEX) is in Stage 2, the uptrend phase. It entered Stage 2 on Feb 10, 2026 and is in week 36. What the four stages mean

Is Pro-Dex in an uptrend?

Yes. Pro-Dex is in a Stage 2 uptrend. It trades 11.5% above its 200-day average, which is rising.

How far is Pro-Dex from its 52-week high?

Pro-Dex closed at $62.38 on Oct 22, 2026, 15.0% below its 52-week high of $73.41. Its 52-week low is $26.36.

How has Pro-Dex performed over the past year?

As of Oct 22, 2026, Pro-Dex is up 139.2% over the past year and up 65.4% so far in 2026.

Which sector and industry is Pro-Dex in?

Pro-Dex is in the Medical Instruments & Supplies industry, part of the Health Care sector.

About this companyHealth Care· Medical Instruments & Supplies

Pro-Dex, Inc. designs, develops, manufactures, and repairs powered surgical instruments for medical device original equipment manufacturers worldwide. It offers autoclavable, battery-powered and electric, and multi-function surgical drivers and shavers that are primarily used in the orthopedic, thoracic, and craniomaxillofacial markets. The company also provides engineering, quality, and regulatory consulting services; manufactures and sells rotary air motors to various industries; and precision machined parts and assemblies for the aerospace and defense industries. Its products are used in hospitals, medical engineering labs, scientific research facilities, and high-tech manufacturing operations. Pro-Dex, Inc. was founded in 1978 and is headquartered in Irvine, California.

Visit company website →

All analytics based on EOD data. Data as of 2026-10-22. Past data patterns are not indicative of future results. This page is a data analytics tool only.